Doxazosin: Effective Blood Pressure and BPH Symptom Management
| Product dosage: 1 mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 120 | $0.33 | $39.56 (0%) | 🛒 Add to cart |
| 180 | $0.30 | $59.34 $53.32 (10%) | 🛒 Add to cart |
| 270 | $0.27 | $89.01 $73.96 (17%) | 🛒 Add to cart |
| 360 | $0.26
Best per pill | $118.68 $94.60 (20%) | 🛒 Add to cart |
| Product dosage: 2 mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.70 | $42.14 (0%) | 🛒 Add to cart |
| 90 | $0.59 | $63.21 $53.32 (16%) | 🛒 Add to cart |
| 120 | $0.54 | $84.28 $64.50 (23%) | 🛒 Add to cart |
| 180 | $0.49 | $126.42 $87.72 (31%) | 🛒 Add to cart |
| 270 | $0.45 | $189.63 $121.26 (36%) | 🛒 Add to cart |
| 360 | $0.43
Best per pill | $252.84 $155.66 (38%) | 🛒 Add to cart |
| Product dosage: 4 mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.20 | $36.12 (0%) | 🛒 Add to cart |
| 60 | $0.97 | $72.24 $58.48 (19%) | 🛒 Add to cart |
| 90 | $0.91 | $108.36 $81.70 (25%) | 🛒 Add to cart |
| 120 | $0.87 | $144.48 $104.06 (28%) | 🛒 Add to cart |
| 180 | $0.83 | $216.72 $149.64 (31%) | 🛒 Add to cart |
| 270 | $0.81 | $325.08 $217.58 (33%) | 🛒 Add to cart |
| 360 | $0.79
Best per pill | $433.44 $285.52 (34%) | 🛒 Add to cart |
Synonyms | |||
Doxazosin is a selective alpha-1 adrenergic receptor antagonist belonging to the quinazoline class of compounds. It is a well-established therapeutic agent primarily indicated for the management of hypertension (high blood pressure) and the treatment of urinary outflow obstruction and associated symptoms stemming from benign prostatic hyperplasia (BPH). Its mechanism of action involves the blockade of postsynaptic alpha-1 adrenoreceptors, leading to peripheral vasodilation and relaxation of smooth muscle in the prostate and bladder neck. This dual action underpins its clinical utility in two distinct patient populations, making it a versatile option in a prescriber’s arsenal.
Features
- Active Ingredient: Doxazosin (as doxazosin mesylate)
- Drug Class: Alpha-1 Adrenergic Blocker (Alpha-1 Antagonist)
- Available Formulations: Oral tablets in standard and extended-release (XL) forms.
- Standard Tablet Strengths: 1 mg, 2 mg, 4 mg, 8 mg.
- Extended-Release (XL) Tablet Strengths: 4 mg, 8 mg.
- Mechanism of Action: Competitive antagonism of alpha-1 adrenoreceptors located on vascular smooth muscle and in the prostate and bladder neck.
Benefits
- Provides effective reduction of both systolic and diastolic blood pressure as a monotherapy or in combination with other antihypertensive agents.
- Significantly improves urinary flow rates and reduces symptoms of BPH, such as hesitancy, weak stream, nocturia, and urgency.
- Offers a favorable effect on lipid profiles, often demonstrating a modest reduction in total cholesterol, LDL cholesterol, and triglycerides.
- May improve insulin sensitivity in hypertensive patients with insulin resistance.
- The extended-release formulation allows for once-daily dosing, improving patient adherence and potentially minimizing peak-dose side effects like dizziness.
Common use
Doxazosin is clinically approved for two primary indications. Its first-line use is in the management of hypertension. It can be used alone or concomitantly with other antihypertensive drug classes such as diuretics, beta-blockers, ACE inhibitors, or calcium channel blockers. Its second major indication is for the treatment of both the obstructive (weak stream, straining) and irritative (nocturia, urgency, frequency) symptoms associated with benign prostatic hyperplasia (BPH). Treatment leads to improved urine flow and a reduction in symptom scores. It is important to note that while doxazosin improves urinary symptoms, it does not reduce the size of the enlarged prostate itself.
Dosage and direction
Hypertension:
- Initial Dose: 1 mg administered once daily, preferably at bedtime to minimize the potential for first-dose syncope (fainting).
- Titration: The dose may be increased to 2 mg, and thereafter to 4 mg, 8 mg, and 16 mg if necessary, based on blood pressure response. Dose adjustments should typically occur at 1-2 week intervals.
- Maintenance Dose: The usual therapeutic dosage range is 2-8 mg daily. Doses above 16 mg daily do not appear to confer additional benefit.
Benign Prostatic Hyperplasia (BPH):
- Initial Dose: 1 mg administered once daily, preferably at bedtime.
- Titration: The dose is titrated upward, typically through 2 mg and 4 mg, to a recommended dose of 4 mg or 8 mg once daily, based on clinical response and tolerability.
- Maximum Dose: 8 mg daily.
Doxazosin XL (Extended-Release):
- For both hypertension and BPH, the recommended initial dose is 4 mg once daily with breakfast. The dose may be increased to 8 mg based on clinical response. The tablets must be swallowed whole and must not be crushed, chewed, or divided.
The antihypertensive effect of a single dose is maintained for 24 hours. A minimum of 2-6 weeks of therapy may be required to achieve the full therapeutic effect for BPH symptoms.
Precautions
First-Dose Effect: A marked decrease in blood pressure, with syncope (fainting) and postural dizziness, can occur within 2-6 hours of the first dose or any subsequent rapid dose increase. This risk is minimized by initiating therapy at the 1 mg dose and administering it at bedtime. Patients should be cautioned to avoid situations where injury could result should syncope occur. Orthostatic Hypotension: Doxazosin can cause a significant drop in blood pressure upon standing from a sitting or lying position (orthostatic hypotension), with symptoms including dizziness, lightheadedness, and palpitations. This is most common during initiation and titration phases. Caution is advised when driving or operating machinery. Priapism: Rare cases of painful, prolonged erection (priapism) have been reported. This condition is a medical emergency requiring immediate intervention to prevent permanent erectile dysfunction. Cataract Surgery: The alpha-1 blocker class of drugs has been associated with Intraoperative Floppy Iris Syndrome (IFIS) during cataract surgery. Ophthalmologists should be informed of the patient’s use of doxazosin prior to surgery. Use in Specific Populations: Use with caution in patients with severe hepatic impairment. Safety and efficacy in children have not been established.
Contraindications
Doxazosin is contraindicated in patients with a known hypersensitivity to doxazosin, other quinazolines (e.g., prazosin, terazosin), or any component of the formulation. It is also contraindicated in patients with a history of orthostatic hypotension and as a treatment for BPH in patients with concomitant hypotension.
Possible side effect
Like all medications, doxazosin can cause side effects, although not everybody gets them. The most common are related to its pharmacological vasodilatory effects.
- Very Common (>10%): Dizziness, headache, fatigue.
- Common (1-10%): Postural dizziness, orthostatic hypotension, somnolence (drowsiness), nausea, dry mouth, edema (peripheral swelling), rhinitis, dyspnea (shortness of breath), asthenia (weakness).
- Uncommon (0.1-1%): Palpitations, tachycardia, chest pain, abdominal pain, diarrhea, vomiting, constipation, flatulence, urinary incontinence, blurred vision, vertigo, nervousness, rash, pruritus (itching), pain.
- Rare (<0.1%): Syncope (fainting), priapism, hepatitis, jaundice, leucopenia, thrombocytopenia.
Drug interaction
Concomitant use of doxazosin with other antihypertensive agents, including diuretics, beta-blockers, ACE inhibitors, and calcium channel blockers, may result in an additive hypotensive effect. Careful monitoring of blood pressure is recommended during coadministration. Concurrent use with phosphodiesterase-5 inhibitors (e.g., sildenafil, tadalafil, vardenafil) used for erectile dysfunction can potentiate the blood pressure-lowering effects and may lead to symptomatic hypotension. This combination should be used with extreme caution. Doxazosin is highly bound to plasma proteins (>98%), and thus might be displaced by other highly protein-bound drugs; however, the clinical significance of this is likely low.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is not remembered until the next day, the patient should skip the missed dose and take the next scheduled dose at the regular time. Patients should never take a double dose to make up for a forgotten one.
Overdose
In the event of an overdose, the primary expected manifestation is exaggerated pharmacological effects, leading to profound hypotension, sometimes accompanied by shock-like states and pronounced dizziness, somnolence, and syncope. Supportive care is the mainstay of treatment. This includes placing the patient in a supine position, with legs elevated, to manage hypotension and facilitate venous return. Active cardiovascular support may be required. Gastric lavage or induced emesis may be considered if ingestion was recent. Vital signs and renal function should be monitored closely. As doxazosin is highly protein-bound, dialysis is not expected to be of significant benefit.
Storage
Store doxazosin tablets at room temperature, between 15°C and 30°C (59°F and 86°F). Keep the medication in its original container, tightly closed, and out of reach of children and pets. Protect from light, moisture, and excessive heat. Do not flush medications down the toilet or pour them into a drain. Dispose of unused or expired medication through a medicine take-back program or according to local guidelines.
Disclaimer
This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The author and publisher are not responsible for any specific health or allergy needs that may require medical supervision and are not liable for any damages or negative consequences from any treatment, action, application, or preparation, to any person reading or following the information in this document.
Reviews
- “As a cardiologist, I find doxazosin to be a valuable add-on therapy for resistant hypertension, particularly in patients with concomitant BPH. The first-dose hypotension is a manageable concern with proper dosing.” – Dr. A. Sharma, MD
- “The extended-release formulation has been a game-changer for my patients with BPH. It offers consistent symptom control with a notably lower incidence of dizziness compared to the immediate-release version we used previously.” – Dr. R. Evans, Urologist
- “Patient adherence is significantly better with the once-daily XL formulation. The clinical efficacy for managing my patients’ blood pressure has been consistent and reliable over long-term use.” – Nurse Practitioner J. Chen
- “While effective, the side effect profile, particularly dizziness and orthostasis, requires careful patient selection and thorough education, especially for our older patient population who are at higher risk for falls.” – Clinical Pharmacist M. Davies